C.Uyemura &C.Uyemura & Co.,Ltd.4966東証スタンダード化学FY ending Mar 2026, consolidated, J-GAAP
Out of every ¥100 of sales, about ¥23 is left as operating profit. Revenue changed +9.5% from the prior year, operating profit +13.3%.
Net margin × asset turnover = ROA; ROA × financial leverage = ROE
Denominators: average assets and average equity. Derived from reported values; ROE is shown only for positive profit and equity.
| Period | Net margin | Asset turnover | ROA | Financial leverage | ROE |
|---|---|---|---|---|---|
| 2022 | 13.4% | 0.71× | 9.6% | 1.40× | 13.4% |
| 2023 | 12.3% | 0.82× | 10.1% | 1.41× | 14.2% |
| 2024 | 13.6% | 0.71× | 9.7% | 1.44× | 14.0% |
| 2025 | 16.8% | 0.67× | 11.3% | 1.44× | 16.3% |
| 2026 | 15.2% | 0.68× | 10.3% | 1.41× | 14.6% |
Financial leverage can raise ROE; a higher value alone does not describe a company's overall condition.
Annual trends in tangible-asset ratios and goodwill balance.
Ratios are derived from reported values. Goodwill is shown only when separately reported; it is not inferred from combined intangible assets. Definition
Track R&D investment and how long operating capital remains tied up before sales turn into cash.
R&D is shown only for years with machine-readable disclosure. Days are estimates using year-end receivables, inventory and payables divided by annual revenue or cost of sales; financial companies are excluded.
| Item | FY ending Mar 2022 | FY ending Mar 2023 | FY ending Mar 2024 | FY ending Mar 2025 | FY ending Mar 2026 |
|---|---|---|---|---|---|
| Revenue | 72,304 | 85,749 | 80,256 | 83,845 | 91,784 |
| Cost of revenue | 47,614 | 58,603 | 52,547 | 51,250 | 55,801 |
| Gross profit | 24,689 | 27,147 | 27,709 | 32,595 | 35,982 |
| SG&A | 10,742 | 12,100 | 12,714 | 13,766 | 14,654 |
| Operating income | 13,947 | 15,046 | 14,995 | 18,829 | 21,327 |
| Pretax income | 14,067 | 15,555 | 15,802 | 20,110 | 20,603 |
| Income tax | 4,386 | 5,010 | 4,881 | 6,032 | 6,656 |
| Net income attributable to owners | 9,682 | 10,546 | 10,921 | 14,078 | 13,946 |
| Operating margin | 19.3% | 17.5% | 18.7% | 22.5% | 23.2% |
Year-end figures from filings. Unreported items are omitted. Interest-bearing debt excludes lease liabilities.
Each bar totals 100% of assets; other is the residual.
| Item | FY ending Mar 2022 | FY ending Mar 2023 | FY ending Mar 2024 | FY ending Mar 2025 | FY ending Mar 2026 |
|---|---|---|---|---|---|
| Cash and equivalents | ¥26.3B | ¥26.5B | ¥32.9B | ¥46B | ¥51.8B |
| Total assets | ¥101.2B | ¥107.3B | ¥118.2B | ¥130.6B | ¥139.6B |
| Net assets | ¥78.7B | ¥84.4B | ¥92.7B | ¥106.1B | ¥116.7B |
| Share capital | ¥1.34B | ¥1.34B | ¥1.34B | ¥1.34B | ¥1.34B |
| Property, plant and equipment | ¥18.7B | ¥22B | ¥23.4B | ¥24.6B | ¥23.8B |
| Intangible assets excluding goodwill | ¥332.7M | ¥349.2M | ¥316M | ¥322M | ¥396M |
| Investment securities | ¥14.8B | ¥15.2B | ¥16.1B | ¥17B | ¥17.6B |
| Current assets | ¥66B | ¥68.2B | ¥76.3B | ¥86.7B | ¥95.9B |
| Current liabilities | ¥17.5B | ¥17.6B | ¥19.8B | ¥18.4B | ¥16.2B |
| Trade payables | ¥4.11B | ¥3.77B | ¥3.6B | ¥3.64B | ¥3.4B |
| Short-term borrowings | ¥457.8M | ¥400M | ¥400M | ¥400M | ¥350M |
| Total liabilities | ¥22.5B | ¥22.9B | ¥25.5B | ¥24.5B | ¥22.9B |
| Equity attributable to owners of parent | ¥72.3B | ¥75.7B | ¥80.7B | ¥91.6B | ¥100B |
| Retained earnings | ¥76.2B | ¥84.6B | ¥85.9B | ¥96.8B | ¥106.2B |
| Treasury stock | -¥6.52B | -¥11.5B | -¥7.87B | -¥7.84B | -¥8.91B |
EDINET (FSA Japan)
有価証券報告書－第98期(2025/04/01－2026/03/31)
EDINET (FSA Japan)
有価証券報告書－第97期(2024/04/01－2025/03/31)
EDINET (FSA Japan)
有価証券報告書－第96期(2023/04/01－2024/03/31)
EDINET (FSA Japan)
有価証券報告書－第95期(2022/04/01－2023/03/31)
EDINET (FSA Japan)
有価証券報告書－第94期(令和3年4月1日－令和4年3月31日)
EDINET (FSA Japan)
有価証券報告書－第93期(令和2年4月1日－令和3年3月31日)
Extracted from XBRL: 50 / Derived from other figures: 1
Spotted an error? Report it (corrections keep the original record)
Markdown with figures, units, periods and sources, ready to paste into ChatGPT or Claude.